atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of ...

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of ...

Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability of VLS-01 (buccal film DMT) in people suffering from treatment-resistant depression

Phase 2 trial begins for psychedelic-based depression treatment

The post Phase 2 trial begins for psychedelic-based depression treatment appeared first on European Medical Journal.

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity - Pipelinereview

BEIJING, China and BRIDGEWATER, NJ, USA I March 10, 2025 I Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2 clinical trial of bofanglutide (research code: GZR18) injection, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) independently developed by Gan & Lee, in the US participants with overweight or obesity. Notably, bofanglutide i…